No Result
View All Result
China Secrets Revealed
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock
No Result
View All Result
China Secrets Revealed
No Result
View All Result
Home Investing

Dow Jones flat as Iran tensions rise; S&P 500, Nasdaq slip

by
April 20, 2026
in Investing
0
Dow Jones flat as Iran tensions rise; S&P 500, Nasdaq slip

Wall Street’s main indexes opened lower on Monday, as renewed tensions between the US and Iran weighed on investor sentiment following a record-setting rally last week.

The Dow Jones Industrial Average gained 28 points, while the S&P 500 slipped 0.17% and the Nasdaq-100 declined about 0.13%.

The pullback comes after a strong run that pushed major indexes to all-time highs, fueled by optimism around a potential de-escalation in the Middle East.

Geopolitical tensions dent sentiment

Markets turned cautious after a fresh escalation in US-Iran tensions over the weekend. Iran moved to close the Strait of Hormuz again after the US seized an Iranian-flagged cargo ship, raising concerns about the durability of a recently announced ceasefire.

Donald Trump said the ship was under US Treasury sanctions and confirmed that American forces had taken custody. Iran, meanwhile, indicated it would not participate in a second round of negotiations with the US.

Oil surge lifts energy stocks

The renewed tensions sent oil prices sharply higher, with crude benchmarks rising around 5% to 6% amid fears of supply disruptions. West Texas Intermediate climbed above $88 per barrel, while Brent crude moved past $95.

The surge in oil prices lifted energy stocks. Exxon Mobil and Chevron each opened in the green, while Occidental Petroleum rose roughly 0.73%.

Market participants noted that equities have become increasingly sensitive to geopolitical headlines, with even minor developments driving sharp swings in risk appetite.

The CBOE Volatility Index, often referred to as Wall Street’s “fear gauge,” rose to a one-week high after eight consecutive sessions of declines, signaling a pickup in market uncertainty.

Earnings and market outlook in focus

Despite the early losses, analysts suggested that the pullback remained relatively contained given the scale of the recent rally. The S&P 500 rose 4.5% last week, while the Nasdaq Composite surged about 7%, marking its 13th consecutive day of gains — a streak not seen since 1992.

“After the Nasdaq has rallied for 13 days in a row on hopes for a deal, we ended the week very overbought on a short term basis. And now the situation with Iran is gotten even more complicated and uncertain on when this conflict will end and when the Strait will fully reopen without fear of attack,” said Peter Boockvar, chief investment officer at OnePoint BFG Wealth Partners in a CNBC report.

“The only question with Monday trade, assuming news doesn’t change again, will be the extent of the market pullback?” he added.

Investors are also turning their attention to the upcoming earnings season, which is expected to provide further insight into how geopolitical tensions are affecting corporate performance and the broader economy.

Defense companies such as Lockheed Martin and RTX, along with technology firms including IBM and ServiceNow, are set to report results later this week. Tesla is expected to kick off earnings for the “Magnificent Seven” on Wednesday.

According to LSEG I/B/E/S data, first-quarter earnings for S&P 500 companies are projected to grow 14.4%, slightly higher than the 13.7% growth recorded a year earlier, setting the stage for a closely watched reporting season.

The post Dow Jones flat as Iran tensions rise; S&P 500, Nasdaq slip appeared first on Invezz

Previous Post

From record inflows to 12% drawdown, what went wrong for Europe?

Next Post

Trump’s Psychedelic Order Speeds Research—but Not Access

Next Post
Trump’s Psychedelic Order Speeds Research—but Not Access

Trump’s Psychedelic Order Speeds Research—but Not Access

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Trump’s Psychedelic Order Speeds Research—but Not Access

Trump’s Psychedelic Order Speeds Research—but Not Access

0
TD Cowen downgrades Molson Coors, lowers price target to $58: Is it time to exit?

TD Cowen downgrades Molson Coors, lowers price target to $58: Is it time to exit?

0
Google’s antitrust ruling draws parallels to Microsoft’s 25-year-old case: Here’s how

Google’s antitrust ruling draws parallels to Microsoft’s 25-year-old case: Here’s how

0
In 2023, Colorado Lawmakers Pushed Back on Cops Practicing Pain Medicine Based on Flawed CDC Guideline

In 2023, Colorado Lawmakers Pushed Back on Cops Practicing Pain Medicine Based on Flawed CDC Guideline

0
Trump’s Psychedelic Order Speeds Research—but Not Access

Trump’s Psychedelic Order Speeds Research—but Not Access

April 20, 2026
Dow Jones flat as Iran tensions rise; S&P 500, Nasdaq slip

Dow Jones flat as Iran tensions rise; S&P 500, Nasdaq slip

April 20, 2026
From record inflows to 12% drawdown, what went wrong for Europe?

From record inflows to 12% drawdown, what went wrong for Europe?

April 20, 2026
Eli Lilly to acquire Kelonia in $7 billion cancer therapy push

Eli Lilly to acquire Kelonia in $7 billion cancer therapy push

April 20, 2026

Recent News

Trump’s Psychedelic Order Speeds Research—but Not Access

Trump’s Psychedelic Order Speeds Research—but Not Access

April 20, 2026
Dow Jones flat as Iran tensions rise; S&P 500, Nasdaq slip

Dow Jones flat as Iran tensions rise; S&P 500, Nasdaq slip

April 20, 2026
From record inflows to 12% drawdown, what went wrong for Europe?

From record inflows to 12% drawdown, what went wrong for Europe?

April 20, 2026
Eli Lilly to acquire Kelonia in $7 billion cancer therapy push

Eli Lilly to acquire Kelonia in $7 billion cancer therapy push

April 20, 2026

Disclaimer: ChinaSecretsRevealed.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 ChinaSecretsRevealed. All Rights Reserved.

No Result
View All Result
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock

Copyright © 2024 ChinaSecretsRevealed. All Rights Reserved.